# Imaware

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imaware

- Industry: Medical Devices & Equipment
- Headquarters: Austin, US
- Website: www.imaware.health
- Latest round: Seed (Jun 1, 2018)
- Investors on record: 1

## About

Based in Texas, US, and founded in 2017, Imaware, Inc. operates as a provider of medical screening and monitoring tests that can be performed at home or remotely. Howard Berman and Jani Tuomi are the co-founders of the company. In January 2023, Imaware, Inc. raised USD 1.5 million in venture debt funding led by McNair Interests and Trinity Biotech.

The company provides monitoring tests for testosterone and vitamin D and screening tests for diabetes, thyroid, prostate cancer, STIs, and immune defense tests. The firm’s home testing kits cover various health aspects, including heart health, sexual health, thyroid function, diabetes risk, vitamin deficiencies, and overall wellness monitoring. The firm allows individuals to gain insights into their health status with tests like the Men's Health & Wellness Test, Women's Health & Wellness Test, Baseline Heart Health Test, and others. Imaware also eliminates the need for scheduling doctor's appointments or traveling to clinics, making health monitoring convenient.

The organization plans to use the January 2023 funding to boost its partnership commercialization efforts and expand its digital health solution offerings.

## Funding rounds

- Seed, Jun 1, 2018 — Undeterred Capital

## Investors

- Undeterred Capital (https://capitalatlas.ai/funds/undeterred-capital) — Seed